Capitolis Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,619
Closed -$930K 99
2022
Q2
$930K Hold
4,619
0.05% 82
2022
Q1
$1.05M Sell
4,619
-6,605
-59% -$1.55M 0.05% 80
2021
Q4
$3.03M Buy
11,224
+4,618
+70% +$1.14M 0.02% 366
2021
Q3
$1.56M Hold
6,606
0.01% 310
2021
Q2
$1.56M Hold
6,606
0.02% 280
2021
Q1
$1.45M Hold
6,606
0.03% 274
2020
Q4
$1.16M Buy
+6,606
New +$1.14M 0.02% 376

Other funds holding LH

Capitolis Advisors's LH Position: Q3 2022 in Review

Capitolis Advisors sold out of Labcorp (LH) in Q3 2022, closing a stake of 4,619 shares — an estimated $930K sold.

Capitolis Advisors first reported a position in LH in Q4 2020 and held it in 7 quarters. The position peaked at $3.03M in Q4 2021. 936 funds tracked by Wall St. Rank hold LH as of Q3 2022.

  • Capitolis Advisors reported no remaining Labcorp position as of Q3 2022 after selling out during the quarter.
  • Capitolis Advisors sold 4,619 Labcorp shares in Q3 2022, an estimated $930K.
  • Capitolis Advisors first reported a position in Labcorp in Q4 2020 and held it in 7 quarters.
  • Capitolis Advisors's Labcorp position peaked at $3.03M in Q4 2021.
  • 936 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on Capitolis Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.